Global initiative IDs keys that could unlock better personalized cancer treatments
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies. Targeting the "right" neoantigens—in a cancer vaccine or a cell ...
Oct 9, 2020
0
36